EV/EBITDA
14.24
-0.62-4.17%
Sat, 28 Dec 2024 00:55:43 GMT
Summary:
Protagonist Therapeutics EV/EBITDA is currently 14.24, with a fall of -0.62 (-4.17%) during the most recent trading day. Over the past year, it has increased by +27.09 (+210.82%). PTGX EV/EBITDA is now -22.48% below its all-time high of 18.37.PTGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -4.2% |
| 1 m1 month | -15.2% |
| 3 m3 months | -12.3% |
| 6 m6 months | +14.6% |
| ytdytd | +213.1% |
| 1 y1 year | +210.8% |
| 5 y5 years | +794.6% |
PTGX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 17.53 | -18.8% | 14.24 | at low |
| 3 m | 3 months | 18.37 | -22.5% | 14.24 | at low |
| 6 m | 6 months | 18.37 | -22.5% | 10.61 | +34.2% |
| 1 y | 1 year | 18.37 | -22.5% | -19.12 | +174.5% |
| 3 y | 3 years | 18.37 | -22.5% | -19.12 | +174.5% |
| 5 y | 5 years | 18.37 | -22.5% | -30.57 | +146.6% |
| alltime | all time | 18.37 | -22.5% | -30.57 | +146.6% |
Protagonist Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 14.24(-213.1%) |
| 2023 | -12.59(+308.8%) |
| 2022 | -3.08(-75.1%) |
| 2021 | -12.37(-1.2%) |
| Date | Value |
|---|---|
| 2020 | -12.52(+435.0%) |
| 2019 | -2.34(+24.5%) |
| 2018 | -1.88(-79.3%) |
| 2017 | -9.10(-15.1%) |
| 2016 | -10.72 |
FAQ
- What is Protagonist Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Protagonist Therapeutics?
- What is PTGX EV/EBITDA year-to-date change?
- What is Protagonist Therapeutics EV/EBITDA year-on-year change?
What is Protagonist Therapeutics EV/EBITDA?
The current EV/EBITDA of PTGX is 14.24
What is the all time high EV/EBITDA for Protagonist Therapeutics?
Protagonist Therapeutics all-time high EV/EBITDA is 18.37
What is PTGX EV/EBITDA year-to-date change?
Protagonist Therapeutics EV/EBITDA has changed by +26.83 (+213.11%) since the beginning of the year
What is Protagonist Therapeutics EV/EBITDA year-on-year change?
Over the past year, PTGX EV/EBITDA has changed by +27.09 (+210.82%)